SynthesisInternational journal of molecular sciences2026
Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials.
Chao-Ming Hung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.